<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Addiction</journal-id><journal-id journal-id-type="iso-abbrev">Addiction</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Addiction (Abingdon, England)</journal-title></journal-title-group><issn pub-type="ppub">0965-2140</issn><issn pub-type="epub">1360-0443</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11766828</article-id><article-id pub-id-type="pmcid-ver">PMC11766828.1</article-id><article-id pub-id-type="pmcaid">11766828</article-id><article-id pub-id-type="pmcaiid">11766828</article-id><article-id pub-id-type="manuscript-id">NIHMS2043992</article-id><article-id pub-id-type="pmid">38192124</article-id><article-id pub-id-type="doi">10.1111/add.16412</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2043992</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2043992</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Longitudinal trajectories of substance use disorder treatment use: A latent class growth analysis using a national cohort in Chile</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3746-578X</contrib-id><name name-style="western"><surname>B&#243;rquez</surname><given-names initials="I">Ignacio</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8441-7046</contrib-id><name name-style="western"><surname>Cerd&#225;</surname><given-names initials="M">Magdalena</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5166-9121</contrib-id><name name-style="western"><surname>Gonz&#225;lez-Santa Cruz</surname><given-names initials="A">Andr&#233;s</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7396-3938</contrib-id><name name-style="western"><surname>Krawczyk</surname><given-names initials="N">Noa</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3016-890X</contrib-id><name name-style="western"><surname>Castillo-Carniglia</surname><given-names initials="&#xC1;">&#193;lvaro</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Center for Opioid Epidemiology and Policy (COEP), Department of Population Health, Grossman School of Medicine, New York University, New York, New York, USA</aff><aff id="A2"><label>2</label>Millennium Nucleus for the Evaluation and Analysis of Drug Policies (nDP), Santiago, Chile</aff><aff id="A3"><label>3</label>Society and Health Research Center and School of Public Health, Facultad de Ciencias Sociales y Artes, Universidad Mayor, Santiago, Chile</aff><aff id="A4"><label>4</label>School of Public Health, Universidad de Chile, Santiago, Chile</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">AUTHOR CONTRIBUTIONS</p><p id="P2"><bold>Ignacio B&#243;rquez:</bold> Conceptualization (lead); data curation (supporting); formal analysis (lead); investigation (lead); methodology (lead); validation (equal); visualization (lead); writing&#8212;original draft (lead); writing&#8212;review and editing (lead) <bold>Magdalena Cerda:</bold> Conceptualization (supporting); methodology (supporting); supervision (equal); writing&#8212;review and editing (equal). <bold>Andr&#233;s Gonz&#225;lez-Santa Cruz:</bold> Data curation (lead); validation (equal); writing&#8212;review and editing (equal). <bold>Noa Krawczyk:</bold> Conceptualization (supporting); supervision (equal); writing&#8212;review and editing (equal). <bold>Alvaro Castillo-Carniglia:</bold> Conceptualization (supporting); funding acquisition (lead); supervision (equal); writing&#8212;review and editing (equal).</p></fn><corresp id="CR1">Correspondence: Ignacio B&#243;rquez, Department of Population Health, New York University Grossman School of Medicine, 180 Madison Avenue, 5th Floor 5-36A, New York, NY 10016, USA. <email>ignacio.borquez@nyulangone.org</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P37">DECLARATION OF INTERESTS</p><p id="P38">None.</p></fn></author-notes><pub-date pub-type="ppub"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>08</day><month>1</month><year>2024</year></pub-date><volume>119</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">480464</issue-id><fpage>753</fpage><lpage>765</lpage><pub-history><event event-type="nihms-submitted"><date><day>10</day><month>01</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-01 00:25:45.780"><day>01</day><month>04</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2043992.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background and aims:</title><p id="P3">Longitudinal studies have revealed that substance use treatment use is often recurrent among patients; the longitudinal patterns and characteristics of those treatment trajectories have received less attention, particularly in the global south. This study aimed to disentangle heterogeneity in treatment use among adult patients in Chile by identifying distinct treatment trajectory groups and factors associated with them.</p></sec><sec id="S2"><title>Design:</title><p id="P4">National-level registry-based retrospective cohort.</p></sec><sec id="S3"><title>Setting and participants:</title><p id="P5">Adults admitted to publicly funded substance use disorder treatment programs in Chile from November 2009 to November 2010 and followed for 9 years (<italic toggle="yes">n</italic> = 6266).</p></sec><sec id="S4"><title>Measurements:</title><p id="P6">Monthly treatment use; type of treatment; ownership of the treatment center; discharge status; primary substance used; sociodemographic.</p></sec><sec id="S5"><title>Findings:</title><p id="P7">A seven-class treatment trajectory solution was chosen using latent class growth analysis. We identified three trajectory groups that did not recur and had different treatment lengths: <italic toggle="yes">Early discontinuation</italic> (32%), <italic toggle="yes">Less than a year in treatment</italic> (19.7%) and <italic toggle="yes">Year-long episode, without recurrence</italic> (12.3%). We also identified a mixed trajectory group that had a long first treatment or two treatment episodes with a brief time between treatments: <italic toggle="yes">Long first treatment, or immediate recurrence</italic> (6.3%), and three recurrent treatment trajectory groups: <italic toggle="yes">Recurrent and decreasing</italic> (14.2%), <italic toggle="yes">Early discontinuation with recurrence</italic> (9.9%) and <italic toggle="yes">Recurrent after long between treatments period</italic> (5.7%). Inpatient or outpatient high intensity (vs. outpatient low intensity) at first entry increased the odds of being in the longer one-episode groups compared with the <italic toggle="yes">Early discontinuation</italic> group. Women had increased odds of belonging to all the recurrent groups. Using cocaine paste (vs. alcohol) as a primary substance decreased the odds of belonging to long one-episode groups.</p></sec><sec id="S6"><title>Conclusions:</title><p id="P8">In Chile, people in publicly funded treatment for substance use disorder show seven distinct care trajectories: three groups with different treatment lengths and no recurring episodes, a mixed group with a long first treatment or two treatment episodes with a short between-treatment-episodes period and three recurrent treatment groups.</p></sec></abstract><kwd-group><kwd>administrative data</kwd><kwd>care trajectory</kwd><kwd>latent class growth analysis</kwd><kwd>longitudinal analysis</kwd><kwd>substance use disorder treatment utilization</kwd><kwd>treatment careers</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>